Metabolic parameters of pretreatment 2-[18F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort study

被引:1
作者
Li, Can [1 ]
Dong, Y. [1 ]
Pan, Yue [1 ,2 ]
Han, Yun [1 ,2 ]
Zhang, Jingfeng [1 ,2 ]
Luan, Xiaohui [1 ,2 ]
Liu, Jiajin [1 ]
Xu, Xiaodan [1 ]
Guan, Zhiwei [1 ]
Wang, Guanyun [1 ,3 ]
Xu, Baixuan [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Nucl Med, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Grad Sch, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Nucl Med Dept, Beijing, Peoples R China
关键词
Gallbladder adenocarcinoma (GBA); 2-[F-18]fluoro-D-glucose positron emission tomography {2-[F-18] FDG PET}; prognosis; survival; metabolic tumor volume (MTV); FDG-PET; CANCER; PREDICTION; SURVIVAL; RESECTION; PATTERNS; VOLUME;
D O I
10.21037/qims-23-1003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The incidence of gallbladder adenocarcinoma (GBA) is relatively low, yet it exhibits a high degree of malignancy and a significantly low 5-year survival rate. The aim of this study was to investigate the prognostic value of pretreatment 2-[F-18]fluoro-D-glucose positron emission tomography {2-[F-18]FDG PET} parameters in predicting outcomes for patients with GBA. Methods: In total, 67 patients with GBA who underwent 2-[F-18]FDG PET/computed tomography (CT) before treatment were retrospectively analyzed at Chinese PLA General Hospital from January 2012 to June 2022. All patients were diagnosed by pathology, and their baseline characteristics and clinical data were collected. The metabolic PET parameters of the primary and metastatic lesions were measured, including the maximum and average standardized uptake values (SUVs), metabolic tumor volume (MTV), and total lesion glycolysis (TLG). The prognostic significance of metabolic parameters and other clinical variables was assessed using Cox proportional hazards regression models. Differences in progression-free survival (PFS) and overall survival (OS) in relation to metabolic parameters were examined using the Kaplan-Meier method. Results: During a median follow-up period of 14.2 months, 43 patients (64.2%) experienced tumor recurrence or progression, and 38 patients (56.7%) died of cancer. In the univariate Cox regression analysis, liver parenchymal invasion (P=0.001), lymph node metastasis (P=0.007), distant metastases (P=0.049), tumor differentiation (P=0.028), surgery (P=0.014), carcinoembryonic antigen (CEA) level (P=0.030), carbohydrate antigen 19-9 (CA19-9) level (P=0.003), TLG (P=0.005), MTV (P<0.001), sum of the TLGs of the primary and metastatic lesions (total TLG, tTLG) (P=0.001), and sum of the MTVs of the primary and metastatic lesions (total MTV, tMTV) (P<0.001) were significant predictors of PFS. In multivariate analysis, MTV was an independent predictor of PFS [hazard ratio (HR) =2.785; 95% confidence interval (CI): 1.204-6.441; P=0.017]. In the univariate Cox regression analysis, liver parenchymal invasion (P=0.001), lymph node metastasis (P=0.027), distant metastases (P=0.036), tumor differentiation (P=0.047), surgery (P=0.002), neutrophil-to-lymphocyte ratio (NLR) (P=0.011), CEA level (P=0.036), CA19-9 level (P<0.001), TLG (P=0.007), MTV (P<0.001), tTLG (P=0.003), and tMTV (P<0.001) were significant predictors of OS. In the multivariate analysis, higher CA19-9 levels >37 U/mL and a greater tMTV (HR =2.961; 95% CI: 1.092-8.024; P=0.033) were predictive of OS. Conclusions: Our study results suggest that pretreatment 2-[F-18]FDG PET parameters can not only assist in the diagnosis of patients with GBA but may also serve as predictive factors for the prognosis of these patients and should thus be applied in their treatment.
引用
收藏
页码:604 / 617
页数:14
相关论文
共 41 条
  • [1] Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis
    Annunziata, Salvatore
    Pizzuto, Daniele Antonio
    Caldarella, Carmelo
    Galiandro, Federica
    Sadeghi, Ramin
    Treglia, Giorgio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (40) : 11481 - 11488
  • [2] Harmonizing standardized uptake value recovery between two PET/CT systems from different manufacturers when using resolution modelling and time-of-flight
    Armstrong, Ian S.
    Thomson, Katharine E.
    Rowley, Lisa M.
    McGowan, Daniel R.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (07) : 650 - 655
  • [3] Pathology of Gallbladder Carcinoma: Current Understanding and New Perspectives
    Bal, Munita Meenu
    Ramadwar, Mukta
    Deodhar, Kedar
    Shrikhande, Shailesh
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 509 - 525
  • [4] [Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
  • [5] Prognostic Value of F-18-Fluorodeoxyglucose PET/Computed Tomography in Non-Small-Cell Lung Cancer
    Cheng, Gang
    Huang, He
    [J]. PET CLINICS, 2018, 13 (01) : 59 - +
  • [6] Tumor Glucose Metabolism and Its Heterogeneity on F-18 FDG PET/CT Provide Better Prognostication in Nonmetastatic Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
    Cho, Hojin
    Kim, Soyoung
    Jo, Kwanhyeong
    Jeong, Yong Hyu
    Kang, Won Jun
    [J]. CANCERS, 2021, 13 (21)
  • [7] Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using 18F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
    Chun, You Jin
    Jeung, Hei-Cheul
    Park, Hyung Soon
    Park, Ji Soo
    Rha, Sun Young
    Choi, Hye Jin
    Lee, Jae-Hoon
    Jeon, Tae Joo
    [J]. YONSEI MEDICAL JOURNAL, 2019, 60 (07) : 604 - 610
  • [8] Predictive and prognostic value of FDG-PET
    de Geus-Oei, Lioe-Fee
    Oyen, Wim J. G.
    [J]. CANCER IMAGING, 2008, 8 (01): : 70 - 80
  • [9] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    Eisenhauer, E. A.
    Therasse, P.
    Bogaerts, J.
    Schwartz, L. H.
    Sargent, D.
    Ford, R.
    Dancey, J.
    Arbuck, S.
    Gwyther, S.
    Mooney, M.
    Rubinstein, L.
    Shankar, L.
    Dodd, L.
    Kaplan, R.
    Lacombe, D.
    Verweij, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) : 228 - 247
  • [10] Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer
    Fendler, Wolfgang Peter
    Tiega, Donfack Beauclair Philippe
    Ilhan, Harun
    Paprottka, Philipp M.
    Heinemann, Volker
    Jakobs, Tobias F.
    Bartenstein, Peter
    Hacker, Marcus
    Haug, Alexander Robert
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) : 1202 - 1208